A recent cross-sectional study involving 124 participants indicated that 56% of patients still exhibited elevated residual gastric contents despite halting incretin agonists for a minimum of 7 days, thus challenging the practice of discontinuing long-acting GLP-1 RAs solely for this duration prior to surgery [19]
[Key Points]
Qualitatively, both self-report and EHR data showed similar distributions for weight loss efficacy (Extended Data Fig
PlexusDx offers both compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan) so you can choose based on your lifestyle preference and comfort level
Activation of mTOR leads to inhibition of autophagy [248], generally observed in ASD patients [242, 245, 251, 256]
If youve already been considering GLP-1 medications for usage in treating obesity or diabetes symptoms, ask your care team how they might help support your substance abuse issues as well